Volume : 09, Issue : 07, July – 2022



Authors :

Bedoor H. Al Qadrah*, Abdulla Al-Sayyari

Abstract :

Background: The utilization of placebos intervention in clinical practice is generally controversial. This study aims to evaluate the use, knowledge, and attitudes about placebos among pediatric doctors and nurses.
Method: A survey-based cross-sectional study was used consisting of 19 questions, including prescribing frequency, type of placebo, indications, perceived effect, and ethical concerns associated with the use of placebos.
Result: Eighty-nine (29.5%) respondents prescribed placebos. The commonest placebo was saline infusion (16.6%). The commonest reason for prescribing placebos was to calm the patient and to stop him complaining (39.1%). Of the participants (83.8%) believed “placebos have therapeutic effects”. 81.5% thought that its effect was psychological. Two-thirds felt that placebo should only be used selectively and 6% of thought that its use should always be permitted. 57.7% of doctors and 32% of nurses (P=0) think the patient should not know about the placebo.
Conclusion: Research about the use of placebo in clinical practice is still insignificant, particularly from the Middle East and in Saudi Arabia. In our study, nearly one-third of the respondents use placebos in clinical practice, which is lower than reported elsewhere. The vast majority felt that placebos are “sometimes effective” and a very small percentage believed that placebo prescription should be always permitted.
Keywords: Placebo, pediatrics, ethical concerns, physicians, nurses

Cite This Article:

Please cite this article in press Bedoor Hassan Al Qadrah et al, Study Of The Views On Placebo And Its Use In The Pediatric Medical And Nursing Practice., Indo Am. J. P. Sci, 2022; 09(7).,

Number of Downloads : 10


1. Lichtenberg P, Heresco-Levy U, Nitzan U. The ethics of the placebo in clinical practice. J Med Ethics. 2004;30(6):551-4.
2. Louhiala P. What do we really know about the deliberate use of placebos in clinical practice? J Med Ethics. 2012;38(7):403-5.
3. Benedetti F. Placebo analgesia. Neurol Sci. 2006;27(2):006-0580.
4. Ahmed M, Kadhim D, Al-Seraya D, Nicholls M, Al Khader Al Sayyari A. Placebo Prescribing Habits And Views In A University Hospital. 2020.
5. Hróbjartsson A, Norup M. The use of placebo interventions in medical practice–a national questionnaire survey of Danish clinicians. Eval Health Prof. 2003;26(2):153-65.
6. Fässler M, Meissner K, Schneider A, Linde K. Frequency and circumstances of placebo use in clinical practice–a systematic review of empirical studies. BMC Med. 2010;8(15):1741-7015.
7. Cherniack EP. Would the elderly be better off if they were given more placebos? Geriatr Gerontol Int. 2010;10(2):131-7.
8. Hammami MM, Hammami S, Aboushaar R, Aljomah AS. Lay People’s Ethical Attitudes To Placebo Treatment: A Q-Methodology Study. Patient Prefer Adherence. 2019;13:1599-617.
9. Petkovic G, Charlesworth JE, Kelley J, Miller F, Roberts N, Howick J. Effects of placebos without deception compared with no treatment: protocol for a systematic review and meta-analysis. BMJ Open. 2015;5(11):2015-009428.
10. Colloca L, Howick J. Placebos Without Deception: Outcomes, Mechanisms, and Ethics. Int Rev Neurobiol. 2018;138:219-40.
11. Faria V, Kossowsky J, Petkov MP, Kaptchuk TJ, Kirsch I, Lebel A, et al. Parental Attitudes About Placebo Use in Children. J Pediatr. 2017;181:272-8.
12. gomez-diaz R, Rodarte N, Robles S, Aguilar-Salinas C. The Ethical Use of Placebo in Pediatric Research. Journal of Clinical Research & Bioethics. 2011;02.
13. Annoni M. The Ethics of Placebo Effects in Clinical Practice and Research. Int Rev Neurobiol. 2018;139:463-84.
14. Hassan T, Fauzi M, Hasan D. Perceptions of placebo therapy among health practitioners in jazan region of saudi arabia. Int J Health Sci. 2011;5(1):45-9.
15. Colloca L, Benedetti F. Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci. 2005;6(7):545-52.
16. Sherman R, Hickner J. Academic physicians use placebos in clinical practice and believe in the mind-body connection. J Gen Intern Med. 2008;23(1):7-10.
17. Bishop FL, Aizlewood L, Adams AE. When and why placebo-prescribing is acceptable and unacceptable: a focus group study of patients’ views. PLoS One. 2014;9(7).
18. Ortiz R, Chandros Hull S, Colloca L. Patient attitudes about the clinical use of placebo: qualitative perspectives from a telephone survey. BMJ Open. 2016;6(4):2015-011012.
19. Pollo A, Benedetti F. The placebo response: neurobiological and clinical issues of neurological relevance. Prog Brain Res. 2009;175:283-94.
20. Kermen R, Hickner J, Brody H, Hasham I. Family physicians believe the placebo effect is therapeutic but often use real drugs as placebos. Fam Med. 2010;42(9):636-42.
21. Raz A, Campbell N, Guindi D, Holcroft C, Déry C, Cukier O. Placebos in clinical practice: comparing attitudes, beliefs, and patterns of use between academic psychiatrists and nonpsychiatrists. Can J Psychiatry. 2011;56(4):198-208.
22. Bąbel P. Use of placebo interventions in primary care in Poland. Med Princ Pract. 2013;22(5):484-8.
23. Simmons K, Ortiz R, Kossowsky J, Krummenacher P, Grillon C, Pine D, et al. Pain and placebo in pediatrics: a comprehensive review of laboratory and clinical findings. Pain. 2014;155(11):2229-35.
24. Nitzan U, Lichtenberg P. Questionnaire survey on use of placebo. Bmj. 2004;329(7472):944-6.
25. Fässler M, Gnädinger M, Rosemann T, Biller-Andorno N. Use of placebo interventions among Swiss primary care providers. BMC Health Serv Res. 2009;9(144):1472-6963.
26. Meissner K, Höfner L, Fässler M, Linde K. Widespread use of pure and impure placebo interventions by GPs in Germany. Family practice. 2011;29:79-85.
27. Tilburt JC, Emanuel EJ, Kaptchuk TJ, Curlin FA, Miller FG. Prescribing “placebo treatments”: results of national survey of US internists and rheumatologists. Bmj. 2008;23(337).
28. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Jama. 2007;297(8):842-57.
29. Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645-58.
30. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277-83.
31. Stanley RJ, Tedesco FJ. Antibiotic-associated pseudomembranous colitis. CRC Crit Rev Clin Radiol Nucl Med. 1976;8(2):255-77.
32. Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC. Pseudomembranous colitis. Dis Mon. 2015;61(5):181-206.
33. Goodwin JS, Goodwin JM, Vogel AV. Knowledge and use of placebos by house officers and nurses. Ann Intern Med. 1979;91(1):106-10.
34. Mommaerts JL, Devroey D. The placebo effect: how the subconscious fits in. Perspect Biol Med. 2012;55(1):43-58.
35. Thompson WG. Placebos: a review of the placebo response. Am J Gastroenterol. 2000;95(7):1637-43.
36. Trogen B, Caplan A, Klass P. The Ethics of Open-Label Placebos in Pediatrics. Pediatrics. 2017;140(2):2016-4328.
37. Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth. 2009;9(12):39-47.